Publication Date
In 2025 | 0 |
Since 2024 | 1 |
Since 2021 (last 5 years) | 2 |
Since 2016 (last 10 years) | 2 |
Since 2006 (last 20 years) | 2 |
Descriptor
Down Syndrome | 2 |
Neurodevelopmental Disorders | 2 |
Program Effectiveness | 2 |
Attention | 1 |
Child Development | 1 |
Children | 1 |
Cognitive Development | 1 |
Drug Therapy | 1 |
Foreign Countries | 1 |
Infants | 1 |
Intervention | 1 |
More ▼ |
Author
El-Hadidy, Mohamed Adel | 1 |
Erdogan Kavlak | 1 |
Metehan Yana | 1 |
Musa Günes | 1 |
Salah El-Din, Ahmed | 1 |
Wahba, Yahya | 1 |
Yahia, Sohier | 1 |
Zeid, Mayada Sabry | 1 |
Publication Type
Journal Articles | 2 |
Reports - Research | 2 |
Education Level
Audience
Location
Turkey | 1 |
Laws, Policies, & Programs
Assessments and Surveys
Bruininks Oseretsky Test of… | 1 |
Stroop Color Word Test | 1 |
What Works Clearinghouse Rating
Metehan Yana; Erdogan Kavlak; Musa Günes – International Journal of Developmental Disabilities, 2024
In this study, we aimed to analyze the incremental effects of sensory integration therapy (SIT) plus neurodevelopmental therapy (NT) versus NT alone on the attention and motor skills in children with Down syndrome (DS). We randomly assigned into experimental (i.e. SIT + NT; n = 21) and control (i.e. NT alone; n = 21) groups. While NT was applied…
Descriptors: Down Syndrome, Sensory Integration, Therapy, Attention
Salah El-Din, Ahmed; Yahia, Sohier; Zeid, Mayada Sabry; El-Hadidy, Mohamed Adel; Wahba, Yahya – Journal of Mental Health Research in Intellectual Disabilities, 2022
Introduction: Down Syndrome (DS) is a common cause of intellectual disability with a possible glial-neuronal disruption. We assessed the effects of Cerebrolysin on the neurodevelopmental outcomes of infants with DS. Methods: This randomized controlled pilot trial included 64 infants with DS. They were allocated into a treatment group (n=32) who…
Descriptors: Down Syndrome, Infants, Child Development, Drug Therapy